Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
Open Access
- 18 May 2009
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 206 (6), 1327-1337
- https://doi.org/10.1084/jem.20082173
Abstract
Macrophages (Mφ) are prominent components of solid tumors and exhibit distinct phenotypes in different microenvironments. We have recently found that tumors can alter the normal developmental process of Mφ to trigger transient activation of monocytes in peritumoral stroma. We showed that a fraction of monocytes/Mφ in peritumoral stroma, but not in cancer nests, expresses surface PD-L1 (also termed B7-H1) molecules in tumors from patients with hepatocellular carcinoma (HCC). Monocytes activated by tumors strongly express PD-L1 proteins with kinetics similar to their activation status, and significant correlations were found between the levels of PD-L1+ and HLA-DRhigh on tumor-infiltrating monocytes. Autocrine tumor necrosis factor α and interleukin 10 released from activated monocytes stimulated monocyte expression of PD-L1. The PD-L1+ monocytes effectively suppressed tumor-specific T cell immunity and contributed to the growth of human tumors in vivo; the effect could be reversed by blocking PD-L1 on those monocytes. Moreover, we found that PD-L1 expression on tumor-infiltrating monocytes increased with disease progression, and the intensity of the protein was associated with high mortality and reduced survival in the HCC patients. Thus, expression of PD-L1 on activated monocytes/Mφ may represent a novel mechanism that links the proinflammatory response to immune tolerance in the tumor milieu.Keywords
This publication has 44 references indexed in Scilit:
- Palettes of Vaccines and Immunostimulatory Monoclonal Antibodies for CombinationClinical Cancer Research, 2009
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availabilityProceedings of the National Academy of Sciences of the United States of America, 2007
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaThe Journal of Experimental Medicine, 2006
- Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and CancerCell, 2006
- TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENTAnnual review of pathology, 2006
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Inflammation and cancerNature, 2002